Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, Nakamura T, Yabusaki H, Aoyama N, Kurita A, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68–74.
van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074–84.
Okamura A, Watanabe M, Mine S, Kurogochi T, Yamashita K, Hayami M, Imamura Y, Ogura M, Ichimura T, Takahari D, et al. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma. Dis Esophagus. 2017;30(9):1–8.
Article CAS PubMed Google Scholar
Zhao Z, Zhang Y, Wang X, Geng X, Zhu L, Li M. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy. Cancer Med. 2020;9(16):5881–8.
Article CAS PubMed PubMed Central Google Scholar
Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, Mendez G, Feliciano J, Motoyama S, Lievre A, et al. Adjuvant nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. N Engl J Med. 2021;384(13):1191–203.
Article CAS PubMed Google Scholar
Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, et al. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2019;20(11):1506–17.
Article CAS PubMed Google Scholar
Kojima T, Shah MA, Muro K, Francois E, Adenis A, Hsu CH, Doi T, Moriwaki T, Kim SB, Lee SH, et al. Randomized Phase III KEYNOTE-181 study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer. J Clin Oncol. 2020;38(35):4138–48.
Article CAS PubMed Google Scholar
Hu Y, Xie C, Yang H, Ho JWK, Wen J, Han L, Chiu KWH, Fu J, Vardhanabhuti V. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete response to Neoadjuvant Chemoradiation in patients with esophageal squamous cell carcinoma. JAMA Netw Open. 2020;3(9):e2015927.
Article PubMed PubMed Central Google Scholar
Jin X, Zheng X, Chen D, Jin J, Zhu G, Deng X, Han C, Gong C, Zhou Y, Liu C, et al. Prediction of response after chemoradiation for esophageal cancer using a combination of dosimetry and CT radiomics. Eur Radiol. 2019;29(11):6080–8.
Ou J, Wu L, Li R, Wu CQ, Liu J, Chen TW, Zhang XM, Tang S, Wu YP, Yang LQ, et al. CT radiomics features to predict lymph node metastasis in advanced esophageal squamous cell carcinoma and to discriminate between regional and non-regional lymph node metastasis: a case control study. Quant Imaging Med Surg. 2021;11(2):628–40.
Article PubMed PubMed Central Google Scholar
Yang M, Hu P, Li M, Ding R, Wang Y, Pan S, Kang M, Kong W, Du D, Wang F. Computed tomography-based Radiomics in Predicting T stage and length of esophageal squamous cell carcinoma. Front Oncol. 2021;11:722961.
Article PubMed PubMed Central Google Scholar
Xie C, Yang P, Zhang X, Xu L, Wang X, Li X, Zhang L, Xie R, Yang L, Jing Z, et al. Sub-region based radiomics analysis for survival prediction in oesophageal tumours treated by definitive concurrent chemoradiotherapy. EBioMedicine. 2019;44:289–97.
Article PubMed PubMed Central Google Scholar
Lu N, Zhang WJ, Dong L, Chen JY, Zhu YL, Zhang SH, Fu JH, Yin SH, Li ZC, Xie CM. Dual-region radiomics signature: integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer. Comput Methods Programs Biomed. 2021;208:106287.
Qiu Q, Duan J, Deng H, Han Z, Gu J, Yue NJ, Yin Y. Development and validation of a Radiomics Nomogram Model for Predicting Postoperative recurrence in patients with esophageal squamous cell Cancer who Achieved pCR after Neoadjuvant Chemoradiotherapy followed by surgery. Front Oncol. 2020;10:1398.
Article PubMed PubMed Central Google Scholar
Tang S, Ou J, Liu J, Wu YP, Wu CQ, Chen TW, Zhang XM, Li R, Tang MJ, Yang LQ, et al. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy. Cancer Imaging. 2021;21(1):38.
Article PubMed PubMed Central Google Scholar
Luo HS, Chen YY, Huang WZ, Wu SX, Huang SF, Xu HY, Xue RL, Du ZS, Li XY, Lin LX, et al. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer. Radiat Oncol. 2021;16(1):201.
Article PubMed PubMed Central Google Scholar
Ou J, Li R, Zeng R, Wu CQ, Chen Y, Chen TW, Zhang XM, Wu L, Jiang Y, Yang JQ, et al. CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study. Cancer Imaging. 2019;19(1):66.
Article PubMed PubMed Central Google Scholar
Jiramongkol Y, Lam EW. Multifaceted oncogenic role of adipocytes in the Tumour Microenvironment. Adv Exp Med Biol. 2020;1219:125–42.
Article CAS PubMed Google Scholar
Carraro A, Trevellin E, Fassan M, Kotsafti A, Lunardi F, Porzionato A, Dall’Olmo L, Cagol M, Alfieri R, Macchi V, et al. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance. Cancer Sci. 2017;108(12):2393–404.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Zhu L, Xia W, Wang F. Anatomy of lymphatic drainage of the esophagus and lymph node metastasis of thoracic esophageal cancer. Cancer Manag Res. 2018;10:6295–303.
Article PubMed PubMed Central Google Scholar
Saito H, Sato T, Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg Radiol Anat. 2007;29(7):531–42.
Cuesta MA, Weijs TJ, Bleys RL, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Ruurda JP, Straatman J, Osugi H, van der Peet DL. A new concept of the anatomy of the thoracic oesophagus: the meso-oesophagus. Observational study during thoracoscopic esophagectomy. Surg Endosc. 2015;29(9):2576–82.
Akiyama Y, Iwaya T, Endo F, Nikai H, Sato K, Baba S, Chiba T, Kimura T, Takahara T, Otsuka K, et al. Thoracoscopic esophagectomy with total meso-esophageal excision reduces regional lymph node recurrence. Langenbecks Arch Surg. 2018;403(8):967–75.
Umeoka S, Koyama T, Togashi K, Saga T, Watanabe G, Shimada Y, Imamura M. Esophageal cancer: evaluation with triple-phase dynamic CT–initial experience. Radiology. 2006;239(3):777–83.
Tan X, Ma Z, Yan L, Ye W, Liu Z, Liang C. Radiomics nomogram outperforms size criteria in discriminating lymph node metastasis in resectable esophageal squamous cell carcinoma. Eur Radiol. 2019;29(1):392–400.
Marchand P. The anatomy and applied anatomy of the mediastinal fascia. Thorax. 1951;6(4):359–68.
Article CAS PubMed PubMed Central Google Scholar
Sheng X, Parmentier JH, Tucci J, Pei H, Cortez-Toledo O, Dieli-Conwright CM, Oberley MJ, Neely M, Orgel E, Louie SG, et al. Adipocytes sequester and metabolize the Chemotherapeutic Daunorubicin. Mol Cancer Res. 2017;15(12):1704–13.
Article CAS PubMed PubMed Central Google Scholar
Katzmarzyk PT, Brown JC, Yang S, Mire EF, Wu XC, Miele L, Ochoa AC, Zabaleta J. Association of Abdominal visceral adiposity and total Fat Mass with Cancer incidence and mortality in White and black adults. Cancer Epidemiol Biomarkers Prev. 2022;31(8):1532–8.
Article PubMed PubMed Central Google Scholar
Jayaprakasam VS, Paroder V, Gibbs P, Bajwa R, Gangai N, Sosa RE, Petkovska I, Golia Pernicka JS, Fuqua JL 3rd, Bates DDB et al. MRI radiomics features of mesorectal fat can predict response to neoadjuvant chemoradiation therapy and tumor recurrence in patients with locally advanced rectal cancer. Eur Radiol 2021.
Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of imaging in Esophageal Cancer Management in 2020: update for radiologists. AJR Am J Roentgenol. 2020;215(5):1072–84.
Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, et al. Worldwide Esophageal Cancer collaboration: clinical staging data. Dis Esophagus. 2016;29(7):707–14.
Article CAS PubMed Google Scholar
Chen J, Lin Y, Cai W, Su T, Wang B, Li J, Wu J, Pan J, Chen C. A new clinical staging system for esophageal cancer to predict survival after definitive chemoradiation or radiotherapy. Dis Esophagus 2018, 31(11).
留言 (0)